Amussen Hunsaker Associates LLC Omeros Corp Transaction History
Amussen Hunsaker Associates LLC
- $645 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding OMER
# of Institutions
112Shares Held
25.4MCall Options Held
317KPut Options Held
556K-
Ingalls & Snyder LLC New York, NY4.59MShares$18.7 Million0.8% of portfolio
-
Black Rock Inc. New York, NY4.1MShares$16.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.22MShares$13.1 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.9MShares$7.76 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.58MShares$6.43 Million0.01% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $256M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...